文献速递血管炎

基于核磁共振的巨细胞动脉炎与风湿性多肌痛序贯血清代谢组学可区分疾病活动与不活动

NMR-based metabolomics in giant cell arteritis and polymyalgia rheumatica sequential sera differentiates active and inactive disease.
PubMed 文献 · Rheumatology (Oxford) · 2024-01-01

研究对50例患者(33例巨细胞动脉炎、17例风湿性多肌痛)在糖皮质激素治疗0、1、6个月三个时间点共110份血清行基于核磁共振的代谢组学分析,发现活动期与缓解期代谢谱不同,N-乙酰糖蛋白和结合磷脂胆碱为疾病活动预测标志物,代谢指纹可区分缓解期巨细胞动脉炎与风湿性多肌痛。

要点

  • 活动期与缓解期血清代谢谱不同,且不依赖于疾病类型。
  • N-乙酰糖蛋白和结合磷脂胆碱为疾病活动的预测标志物。
  • 活动期苯丙氨酸升高,谷氨酰胺、丙氨酸和肌酐降低。

核心结论

  • 血清代谢组核磁共振谱可识别并提出炎症的敏感生物标志物。
  • 糖皮质激素治疗后的代谢组改变可能为未来类固醇所致副作用提供预测因素。

研究设计与样本

  • 研究纳入50例患者(33例巨细胞动脉炎和17例风湿性多肌痛),在糖皮质激素治疗0个月(V1:活动期)、1个月和6个月(V2和V3:缓解期)三个时间点共采集110份血清样本。
  • 对血清样本行基于核磁共振的代谢组学分析,并采用多变量和单变量统计分析揭示治疗后的代谢组改变。

主要发现

  • 活动期与缓解期之间识别出不同的代谢谱,且不依赖于疾病类型。
  • N-乙酰糖蛋白和结合磷脂胆碱成为疾病活动的预测标志物。
  • 21种小分子中有4种水平改变,包括活动期苯丙氨酸水平升高,谷氨酰胺、丙氨酸和肌酐降低。
  • 代谢指纹在缓解期可区分巨细胞动脉炎与风湿性多肌痛。
  • 巨细胞动脉炎和风湿性多肌痛患者表现出特征性脂质改变,作为糖皮质激素治疗的反应和/或不良反应。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: GCA is an inflammatory disease following a chronic, relapsing course. The metabolic alterations related to the intense inflammatory process during the active phase and the rapid impact of steroid treatment remain unknown. This study aims to investigate the serum metabolome in active and inactive disease states. METHODS: A total of 110 serum samples from 50 patients (33 GCA and 17 PMR) at three time points-0 (V1: active disease), 1 and 6 months (V2 and V3: remission)-of treatment with glucocorticoids (GCs) were subjected to NMR-based metabolomic analysis. Multi- and univariate statistical analyses were utilized to unveil metabolome alterations following treatment. RESULTS: Distinct metabolic profiles were identified between activity and remission, independent of disease type. N-acetylglycoproteins and cholines of bound phospholipids emerged as predictive markers of disease activity. Altered levels of 4 of the 21 small molecules were also observed, including increased levels of phenylalanine and decreased glutamine, alanine and creatinine in active disease. Metabolic fingerprinting discriminated GCA from PMR in remission. GCA and PMR patients exhibited characteristic lipid alterations as a response and/or adverse effect of GC treatment. Correlation analysis showed that several identified biomarkers were further associated with acute phase reactants, CRP and ESR. CONCLUSION: The NMR profile of serum metabolome could identify and propose sensitive biomarkers of inflammation. Metabolome alterations, following GC treatment, could provide predictors for future steroid-induced side effects.

来源:Rheumatology (Oxford),查看原文。版权归原作者所有。

引用

  1. Iliou A, Argyropoulou OD, Palamidas DA, et al. NMR-based metabolomics in giant cell arteritis and polymyalgia rheumatica sequential sera differentiates active and inactive disease. Rheumatology (Oxford). 2024. PMID: 37935429. doi:10.1093/rheumatology/kead590

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。